ABT
Abbott Laboratories Earnings
$114.05
Earnings Summary
Revenue | $10635Mn |
Net Profits | $1646Mn |
Net Profit Margins | 15.48% |
Abbott Laboratories’s revenue jumped 4.85% since last year same period to $10635Mn in the Q3 2024. On a quarterly growth basis, Abbott Laboratories has generated 2.49% jump in its revenue since last 3-months.
Abbott Laboratories’s net profit jumped 14.62% since last year same period to $1646Mn in the Q3 2024. On a quarterly growth basis, Abbott Laboratories has generated 26.42% jump in its net profits since last 3-months.
Abbott Laboratories’s net profit margin jumped 9.32% since last year same period to 15.48% in the Q3 2024. On a quarterly growth basis, Abbott Laboratories has generated 23.35% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Abbott Laboratories post its latest quarter earningsEPS Estimate Current Quarter | 1.2 |
EPS Estimate Current Year | 1.2 |
Abbott Laboratories’s earning per share (EPS) estimates for the current quarter stand at 1.2 - a 9.09% jump from last quarter’s estimates.
Abbott Laboratories’s earning per share (EPS) estimates for the current year stand at 1.2.
Key Ratios
Key ratios of the Abbott Laboratories post its Q3 2024 earningsEarning Per Share (EPS) | 1.21 |
Dividend Per Share (DPS) | 0.55 |
Abbott Laboratories’s earning per share (EPS) jumped 6.14% since last year same period to 1.21 in the Q3 2024. This indicates that the Abbott Laboratories has generated 6.14% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Abbott Laboratories declared 0.55 dividend per share during the earnings announcement for Q3 2024.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2024-10-31 | 1.2 | 1.21 | 0.83% |
2024-07-31 | 1.1 | 1.14 | 3.64% |
2024-05-02 | 0.95 | 0.98 | 3.16% |
₹0 US Stocks a/c Opening Fee